Mettler-Toledo International, Inc. $MTD Shares Acquired by Wealthfront Advisers LLC

Wealthfront Advisers LLC grew its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 38.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,115 shares of the medical instruments supplier’s stock after purchasing an additional 310 shares during the quarter. Wealthfront Advisers LLC’s holdings in Mettler-Toledo International were worth $1,310,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Mettler-Toledo International by 13.3% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier’s stock valued at $2,929,000 after purchasing an additional 292 shares in the last quarter. Russell Investments Group Ltd. raised its stake in shares of Mettler-Toledo International by 29.0% in the 1st quarter. Russell Investments Group Ltd. now owns 116,502 shares of the medical instruments supplier’s stock valued at $137,548,000 after purchasing an additional 26,171 shares in the last quarter. IFM Investors Pty Ltd raised its stake in Mettler-Toledo International by 7.0% during the first quarter. IFM Investors Pty Ltd now owns 4,274 shares of the medical instruments supplier’s stock worth $5,047,000 after acquiring an additional 280 shares during the period. Legato Capital Management LLC lifted its holdings in Mettler-Toledo International by 107.7% in the first quarter. Legato Capital Management LLC now owns 2,050 shares of the medical instruments supplier’s stock worth $2,421,000 after acquiring an additional 1,063 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. lifted its holdings in Mettler-Toledo International by 46.7% in the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,829 shares of the medical instruments supplier’s stock worth $9,245,000 after acquiring an additional 2,493 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. This trade represents a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director owned 283 shares in the company, valued at $368,154.70. This represents a 78.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 1,827 shares of company stock worth $2,371,208. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Trading Down 1.5%

Shares of NYSE:MTD opened at $1,373.40 on Friday. The firm’s 50 day moving average is $1,304.55 and its two-hundred day moving average is $1,218.30. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,454.68. The firm has a market capitalization of $28.29 billion, a P/E ratio of 34.78, a PEG ratio of 4.19 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same quarter last year, the business earned $9.65 earnings per share. Mettler-Toledo International’s revenue was up 3.9% compared to the same quarter last year. Analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on MTD shares. Robert W. Baird raised their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. JPMorgan Chase & Co. raised their target price on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Barclays raised their target price on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a report on Thursday, October 2nd. Citigroup raised their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a report on Thursday, August 21st. Finally, Bank of America raised their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.